15. Immediately report spills and accidents resu lting in overt exposure to recombinant DNA molecules to the Institutional Biosafety Committee and NIH/OSP (Office of Science Policy). Send reports to the Office of Science Policy, National Institutes of Health, 6705 Rockledge Drive, Suite 750, MSC 7985, Bethesda, MD 20892-7985. Phone (301) 496-9838. Provide medical evaluation, surveillance, and treatment as appropriate and mainta in written records of the event. For more information about biohazard risk group classification and biohazard safety levels see: xNIH Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines). See current version at: http://osp.od.nih.gov/sites/def ault/files/NIH_Guidelines.html Version Date: 12/5/17 Abbreviated Title : Enzalutamide in non-met CSPC 57xBiosafety in Microbiological and Biomedic al Laboratories; U. S.